Global Synchronized Oncology Development: Integrating High-Impact Regions to Accelerate Trial Readiness

How the UK’s largest Passivhaus school uses digital twins to turn complex building data into real-time operational intelligence and measurable sustainability outcomes.

17

June

  • 3pm London 10am New York
  • Free
  • Why attend?
  • Speakers
  • Contact Us

Why attend?

Speakers

Select a speaker to learn more

Back
Adam Callahan, MS, MBA
VP Global Therapeutic Area Head, Oncology & Hematology, Caidya

Adam Callahan is VP Global Therapeutic Area Head, Oncology & Hematology at Caidya. Adam brings nearly 30 years of experience and a strong record of building high-performing, global teams that drive clinical programs for regulatory approval and commercialization of therapies. Adam leads a team of medical, scientific, and clinical development experts who engage early and often to help refine sponsor strategies, improve targeting, and accelerate delivery.

Adam’s teams also bring an adeptness in molecule-to-market strategies and operational excellence. Adam’s operational acumen ensures Caidya’s ability to provide development strategies while delivering exceptional experiences for our clients.

Next speaker

Enquiry